Clinical trial
Study to Evaluate Initiation of Stalevo in Early Wearing-off
NCT00462007 · Orion Corporation, Orion Pharma, Industry · Completed
Key facts
| NCT number | NCT00462007 |
|---|---|
| Title | Study to Evaluate Initiation of Stalevo in Early Wearing-off |
| Official title | Efficacy and Safety of Stalevo® in Subjects With Early Wearing-off Identified Using a Screening Tool WOQ-9; an Open, Non-randomised, Multinational, Multicentre 6-week Direct Switch Study in Levodopa-treated Parkinson's Disease Patients |
| Acronym | SENSE |
| Lead sponsor | Orion Corporation, Orion Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Stalevo |
| Enrollment | 115 |
| Start date | Sep 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 18, 2007 |
| Last update posted | Apr 21, 2015 |
| Countries | Germany, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: